Curzerene
Curzerene is a sesquiterpenoid compound derived from turmeric and other Curcuma species that demonstrates significant antidepressant and anticancer activities. This bioactive compound works by modulating neurotransmitter systems and inhibiting tumor cell proliferation through multiple molecular pathways.

Origin & History
Curzerene is a guaiane-type sesquiterpene hydrocarbon isolated from essential oils of plants in the Apiaceae family, primarily Curcuma wenyujin (turmeric relative), Curcuma longa (turmeric), and Eugenia uniflora (pitanga leaves). It is extracted via steam distillation or hydrodistillation of plant material, followed by chromatographic purification, and features a bicyclic guaiene skeleton with a characteristic furan ring.
Historical & Cultural Context
While isolated curzerene has no direct traditional use history, it naturally occurs in Curcuma species used for centuries in Traditional Chinese Medicine for anti-inflammatory and anticancer purposes. Curcuma wenyujin rhizomes have been traditionally used for stomach pain and tumors, while Eugenia uniflora leaves are used in Brazilian folk medicine for wounds and inflammation.
Health Benefits
• Anti-depressant effects: Reduced depression-like behaviors in mice comparable to fluoxetine, improving forced swim test and sucrose preference (preliminary evidence from PMID: 41371991) • Anti-cancer properties: Inhibited glioblastoma tumor growth and prolonged survival in mice without toxicity (preliminary evidence from PMID: 35048517) • Neuroprotection: Reduced neuroinflammation via HMGB1/RAGE/TLR4/NF-κB pathway inhibition and decreased TNF-α/IL-1β (preliminary evidence from PMC12782868) • Anti-tumor activity: Suppressed lung adenocarcinoma and hepatocellular carcinoma growth in mouse models (preliminary evidence from PMID: 27286338, 39047236) • Gut microbiome modulation: Restored beneficial gut bacteria and increased short-chain fatty acid production in depression models (preliminary evidence from PMID: 41371991)
How It Works
Curzerene exerts antidepressant effects by modulating serotonergic pathways and potentially influencing monoamine neurotransmitter levels in the brain. Its anticancer activity involves inhibiting glioblastoma cell proliferation and inducing apoptosis through disruption of cellular signaling pathways. The compound appears to target multiple molecular mechanisms simultaneously, contributing to its therapeutic potential.
Scientific Research
No human clinical trials have been conducted on curzerene; all evidence comes from preclinical studies using cell lines and rodent models. Key studies include depression models in C57BL/6 mice (n=6-8 per group, PMID: 41371991), glioblastoma studies in nude mice (PMID: 35048517), and lung cancer models (PMID: 27286338).
Clinical Summary
Preclinical studies in mice demonstrated that curzerene reduced depression-like behaviors comparable to fluoxetine treatment, showing improved performance in forced swim tests and increased sucrose preference. Animal studies also revealed significant inhibition of glioblastoma tumor growth with prolonged survival rates and no observable toxicity. However, current evidence is limited to preliminary animal research, with no human clinical trials available. The therapeutic potential remains promising but requires further clinical validation.
Nutritional Profile
Curzerene is a pure bioactive sesquiterpene compound (molecular formula: C15H20O, molecular weight: 216.32 g/mol), not a whole food or nutritional ingredient, and therefore has no macronutrient, micronutrient, vitamin, mineral, or fiber content. It is a furanosesquiterpene naturally occurring as a minor constituent in essential oils of Commiphora myrrha (myrrh) and related Burseraceae species, typically present at trace concentrations (estimated <1-5% of total essential oil composition depending on source plant and extraction method). As a pure compound, it consists entirely of carbon, hydrogen, and oxygen in a bicyclic furanoid sesquiterpene structure. Bioavailability data in humans is not yet established; preclinical (mouse) pharmacokinetic data suggests central nervous system penetration given observed neurological and antidepressant effects (PMID: 41371991). Its lipophilic nature (logP estimated >2 based on structural class) suggests favorable passive membrane permeability and potential for oral absorption, though first-pass metabolism details remain uncharacterized. No dietary reference intake, tolerable upper limit, or established therapeutic dose in humans has been defined. All current efficacy data derives from in vitro and rodent models.
Preparation & Dosage
No human dosages established. Preclinical studies used: oral administration 15-30 mg/kg for 14 days (depression models); intraperitoneal 20-30 mg/kg equivalent every other day for 4 weeks (cancer models); up to 135 mg/kg daily (lung cancer). Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Curcumin, Germacrone, Omega-3 fatty acids, Probiotics, Quercetin
Safety & Interactions
Safety data for curzerene is extremely limited, with only preliminary animal toxicity studies showing no adverse effects at tested doses. No human safety studies, drug interactions, or contraindications have been established. Pregnant and breastfeeding women should avoid curzerene due to lack of safety data. Potential interactions with antidepressants, anticoagulants, or chemotherapy drugs remain unknown and require medical consultation.